Thus, overall, we provide data from two distinct experimental assays to show that murine SCLC cell lines are highly sensitive to ATR- and CHK1 inhibition, compared to murine NSCLC cells, which were largely resistant. This evidence concerns the gene CHEK1 and small cell lung carcinoma.